LHDXQ — Lucira Health Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$10.36m
- $93.06m
U.S. STOCKS ON THE MOVE-Warby Parker, NV5 Global, Absci
U.S. STOCKS ON THE MOVE-Cyclacel, Major U.S. banks, Gold miners
U.S. STOCKS ON THE MOVE-Energy firms, WeWork, aTyr Pharma
Lucira Health up as Canada authorizes COVID, flu test
Brief: Lucira Health announces Health Canada authorization of 99% accurate at-home covid & flu test
Lucira Health Inc reports results for the quarter ended in March - Earnings Summary
Brief: Lucira Health Reports Qtrly EPS $0.31
Brief: Lucira Health Reports Q1 Revenue Of $90.5 Million
Brief: Lucira Files For Authorization Of First-Of-Its-Kind Covid-19 & Flu At-Home Molecular Test
Lucira Health Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Lucira Receives CE Mark For Both COVID-19 & Flu And COVID-19 Molecular Tests
Brief: Lucira Health's Covid-19 & Flu At-Home Molecular Test Shows Positive Clinical Study Results
Brief: Lucira Health's PCR-Quality At-Home Covid-19 Test Now Available Direct To Consumers In Canada
Brief: Lucira Health Inc Says On March 8, Provided Notice Of Termination Of Patent License Agreement Dated July 15, 2020, By And Between Co And Eiken Chemical
Lucira Health Inc reports results for the quarter ended in December - Earnings Summary
Brief: Lucira Health Announces Fourth Quarter And Full Year 2021 Results
Lucira Health Inc expected to post a loss of 55 cents a share - Earnings Preview
Brief: Lucira Health Secures Debt Facility Of Up To $80 Million From Hercules Capital And Silicon Valley Bank
Brief: Lucira Health Commits 2 Million At-Home Molecular Covid-19 Test Kits On Amazon